Lab / Precision gut microbiome diagnostics and FMT bank; largest multi-ethnic Asian microbiome database

AMILI

P4 Healthtech & Diagnostics

AMILI is Southeast Asia's leading precision gut microbiome company, founded in 2019 in Singapore, operating the region's first and only gut microbiome transplant bank and building the world's largest multi-ethnic Asian gut microbiome database. The company offers clinical gut health testing, microbiome restoration therapy, AI-powered analytics for healthcare partners, and physician-guided probiotic programs. Backed by Vulcan Capital and East Ventures, it collaborates with NUS, NUH, and Monash University.

Back to the Atlas